Individuals with elevated levels of cholesterol are more likely to develop Alzheimer's disease compared to other people, researchers from Kyushu University in Fukuoka, Japan, wrote in the journal Neurology. Kensuke Sasaki, MD, PhD wrote that there was a close association between high cholesterol...
Researchers at the University of British Columbia may have discovered that a profusion of blood vessels may explain how Alzheimer's disease destroys the brain. Although previous Alzheimer's research concentrated mainly on the death of cells in the walls of blood vessels or in brain tissue, a...
University of British Columbia scientists may have uncovered a new explanation for how Alzheimer's disease destroys the brain - a profusion of blood vessels. While the death of cells, whether they are in the walls of blood vessels or in brain tissue, has been a major focus of Alzheimer's disease...
Universitätsmedizin Berlin and Universitätsklinik Freiburg succeeded in documenting how the immune system can counteract the advancement of Alzheimer's disease. Within the scope of their neuroscience paper they showed that certain scavenger cells in the immune system, so-called macrophages...
A new study suggests that the relationship between brain shrinkage and memory loss in Alzheimer's disease changes across the age spectrum. The research is published in the August 10, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology. "Those who are 85 and...
Universitätsmedizin Berlin, Universitätsklinikum Bonn, and Deutsches Zentrum für Neurodegenerative Erkrankungen in Bonn succeeded for the first time in demonstrating that even in merely subjective cases of memory deterioration changes may be visible in certain brain structures. The study...
Neutrons have shown the movement of cholesterol between and within cells takes far longer than previously thought. Findings could impact the treatment of a range of diseases linked to abnormal rates of cholesterol transfer. Scientists using neutron scattering at the Institut Laue-Langevin (ILL)...
When her mother was diagnosed with Alzheimer's disease in 2010, Dr. Denise Canchola immediately recognized the importance of enrolling her in a clinical trial. But even Dr. Canchola, a Psychiatric Nurse Practitioner based in Pompano Beach, FL, needed help and resources to search for clinical...
Today the Alzheimer's Association® in conjunction with GE Healthcare held a "Women and Alzheimer's: A Global Perspective" panel discussion during the Alzheimer's Association International Conference 2011 (AAIC). The event brought together leaders in the Alzheimer's field and revealed new data...
The Gladstone Institutes have announced plans to create a Center for Comprehensive Alzheimer's Disease Research, offering new hope for the millions of families stricken by this debilitating neurodegenerative disease. A $6 million lead gift from the S.D. Bechtel, Jr. Foundation will help launch...
What if you were told you carried a gene that increases your risk for Alzheimer's disease? And what if you were told this gene starts to do its damage not when you're old but when you're young? Brace yourself. Scientists know there is a strong genetic component to the development of late-onset...
Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's. These brain regions...
Anavex Life Sciences Corp., ("Anavex", OTCBB: AVXL) has announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead compound for Alzheimer's disease. "We are pleased that the first volunteers have been...
Anavex Life Sciences Corp., ("Anavex", OTCBB: AVXL) has announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company's lead compound for Alzheimer's disease. "We are pleased that the first volunteers have been...
Television presenter Jamie Darling is calling on people from Yorkshire and beyond to put on their trainers and help raise funds to fight dementia at the launch of the Bupa Great Yorkshire Run. Taking place in Sheffield on 19 April, Jamie will lead a stellar Yorkshire-born team including ITN...
The Alzheimer's Association joins the Shriver family and the nation in mourning the passing of Sargent Shriver. Few people have had the impact on our nation that Mr. Shriver did. His unwavering dedication to the excellence and the ideal of public service laid a groundwork that Americans...
The capacity to remember that a zebra has stripes, or that a giraffe is a four-legged mammal, is known as semantic memory. It allows us to assign meaning to words and to recall general knowledge and concepts that we have learned. The deterioration of these capacities is a defining feature of...
Santander staff across the UK have joined forces with Alzheimer's Society to raise a national target of £450,000 to help people with dementia and their carers. The partnership will see Santander employees across its UK branch network carrying out national and regional fundraising initiatives...
As the leading care, research and advocacy organization for Alzheimer's disease, the Alzheimer's Association® applauds Congress for passage of the National Alzheimer's Project Act (S. 3036, H.R. 4689), a significant step forward in the fight against Alzheimer's disease. The National Alzheimer's...
The human risk of developing both Alzheimer's disease and heart attack is genetically linked, leading the way to a genetic test earlier on in life, researchers from the University of Bologna wrote in the Journal of Alzheimer's Disease. In fact, the authors claim the genetic test is already...